ASTROCYTOMA
Clinical trials for ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in fight against recurrent brain cancer
Disease control OngoingThis early-stage study is testing the safety and initial effects of combining two drugs, vorasidenib and pembrolizumab, in adults with a recurrent or worsening type of brain tumor called glioma. The goal is to see if this combination can help control the cancer by boosting the im…
Matched conditions: ASTROCYTOMA
Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Tracking Kids' health years after brain tumor treatment
Disease control OngoingThis study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effe…
Matched conditions: ASTROCYTOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Repurposed transplant drug enters fight against deadly brain cancer
Disease control OngoingThis early-stage trial is testing whether adding a drug called mycophenolate mofetil (MMF) to standard glioblastoma treatment is safe and might make the cancer more sensitive to chemotherapy. MMF is an immunosuppressant commonly used to prevent organ rejection after transplants. …
Matched conditions: ASTROCYTOMA
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists weaponize cold sore virus to fight deadly brain tumors
Disease control OngoingThis is a first-in-human safety study testing a genetically engineered virus, rQNestin34.5v.2, as a potential treatment for recurrent malignant brain tumors (gliomas). The virus is designed to infect and kill only cancer cells while sparing healthy brain tissue. The main goals ar…
Matched conditions: ASTROCYTOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC